Vol. 16 No. 4 (2010)

DOI: https://doi.org/10.5912/jcb.v16i4

Published: 2010-10-01

Editorial

For success in biotechnology, look beyond biotechnology

Yali Friedman
- PDF

Commentary

Federal bureaucrats slip on oil spill

Henry I Miller
- Requires Subscription PDF (USD 25)

Article

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public

David R Williams, Richard W Pouder
- PDF
Algae and Biodiesel: Patenting energized as green goes commercial

Matthew R Preiss, Stanley P Kowalski
- Requires Subscription PDF (USD 25)
Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market

Thani Jambulingam, WaQar Ghani, Rajneesh Sharma
- Requires Subscription PDF (USD 25)
Exploratory assessment of the current EU regulatory framework for development of advanced therapies

Pawanbir Singh, Laure BrÃ©vignon-Dodin, Satya P Dash
- Requires Subscription PDF (USD 25)
Patenting of microorganisms: Systems and concerns

Ramkumar Balachandra Nair, Pratap Chandran Ramachandranna
- Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

Legal and Regulatory Update

Gerry Kamstra
- Requires Subscription PDF (USD 25)
The aftermath of Bilski

Thomas C Meyers, Adam M Schoen
- Requires Subscription PDF (USD 25)
Commentary regarding decision in Bilski from a biotech perspective

Thomas J Kowalski, Heidi E Lunasin, Deborah L Lu, Brian M McGuire, Frank J DeRosa
- Requires Subscription PDF (USD 25)

Book Review

Book Review: Biodesign: The process of innovating medical technologies

Randall Tagg, Catalina Bravo
- Requires Subscription PDF (USD 25)